An Unusual Case of Severe Metabolic Acidosis in MICU: SGLT2 Inhibitor-Associated Diabetic Ketoacidosis

Authors

Hongchuan H. Coville MD, HCA HealthcareFollow
Andrea Ramirez, HCA HealthcareFollow
Christopher Bray, HCA HealthcareFollow

Division

North Florida

Hospital

North Florida Regional Medical Center

Document Type

Abstract

Publication Date

1-2020

Keywords

diabetic ketoacidosis, diabetes mellitus, Sodium-Glucose Transporter 2 Inhibitors

Disciplines

Endocrine System Diseases | Endocrinology, Diabetes, and Metabolism | Internal Medicine | Nutritional and Metabolic Diseases

Publisher or Conference

Critical Care Medicine Journal

Recommended Citation

Coville H, Ramirez A, Bray C. 1399: AN UNUSUAL CASE OF SEVERE METABOLIC ACIDOSIS IN THE MICU: SGLT2 INHIBITOR-ASSOCIATED DKA. Critical Care Medicine. 2020;48(1):676. doi:10.1097/01.ccm.0000645512.31534.c9